MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517039256 A) filed by Adora Animal Health Corporation, Franklin, U.S.A., on April 23, for 'storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions.'
Inventor(s) include Vaughn, Thomas, Michael; Harrison, Joshua, Alan; Popp, Karl, F.; Fairfax, David, J; D'Ambra, Thomas, Edward; and Quinn, John.
The application for the patent was published on Aug. 8, under issue no. 32/2025.
According to the abstract released by the Intellectual Property India: "One aspect of the present application relates to a pharmaceutical composition comprising a sulfated glycosaminoglycan having an average molecular weight ranging from 3,000 to 15,000 Daltons, a skin penetrating agent, where the skin penetrating agent promotes transdermal penetration of the sulfated glycosaminoglycan when applied to intact skin surfaces, and a pharmaceutical carrier for topical application, where the pharmaceutical carrier is mixed with the sulfated glycosaminoglycan and the skin penetrating agent. This composition is useful in carrying out a method of treating a subject for pain, joint stiffness, soft tissue injury, connective tissue disorders, and/or muscle soreness."
The patent application was internationally filed on Sept. 28, 2023, under International application No.PCT/US2023/033947.
Disclaimer: Curated by HT Syndication.
